Advertisement

Stoffwechselerkrankungen des Nervensystems

  • G. Göhlich-Ratmann
  • T. Voit

Zusammenfassung

Stoffwechselerkrankungen können sich klinisch auf verschiedene Weise präsentieren:
  • Die Kinder entwickeln sich zunächst normal und erleiden dann einen plötzlichen Entwicklungs-knick. Diese Form ist am leichtesten zu diagnostizieren.

  • Die Entwicklungsstörung verläuft schleichend und ist v.a. für die nächsten Bezugspersonen anfänglich nicht nachvollziehbar.

  • Die Kinder kommen im Rahmen einer akuten Stoffwechselkrise erstmals ins Krankenhaus.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zitierte Literatur

  1. Aicardi J (1992) Diseases of the nervous system in childhood (clinics in developmental medicine, Nr. 115–118). Mac Keith, London, p 381Google Scholar

Weiterführende Literatur

  1. Adams RD, Victor M, Ropper AH (1997) Principles of neurology, 6th edn. McGraw-Hill, LondonGoogle Scholar
  2. Aubourg P, Blanche S, Jambaqué E et al. (1990) Reversal of early neurologic and neuroradiologic manifestations of x-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860–1866PubMedCrossRefGoogle Scholar
  3. Berginer VM, Salen G, Shefer S (1984) Longterm treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311:1649–1652PubMedCrossRefGoogle Scholar
  4. Boedecker HJ, Mellmann WJ, Tedesco TA, Croce CM (1975) Assignment of the human gene for hex B to chromosome 5. Exp Cell Res 93:468PubMedCrossRefGoogle Scholar
  5. Brady RO, Barton NW, Grabowski GA (1993) The role of neurogenetic in Gaucher disease. Arch Neurol 50:1212–1224PubMedCrossRefGoogle Scholar
  6. Bravermann N, Steel G, Obie C, Moser A, Moser H, Gould SJ, Valle D (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is reponsible for rhizomelic chondrodysplasia punctata. Nat Genet 15: 369–376CrossRefGoogle Scholar
  7. Brusilow SW, Maestri NE (1996) Urea cycle disorders: diagnosis, pathophysiology and treatment. Adv Pediatr 46:127–170Google Scholar
  8. Deufel T, Mönch E, Paetzke I, Przyrembel H, Wendel U, Willichowski E (1996) Diagnostik und Therapie von mitochondrialen (Encephalo-) Myopathien. Empfehlungen der Arbeitsgemeinschaft „Pädiatrische Stoffwechselstörungen“. Monatsschr Kinderheilkd: 765–768Google Scholar
  9. De Vivo DC, Garcia-Alvarez M, Ronen G, Trifiletti G (1995) Glucose transport protein deficiency: An emerging syndrome with therapeutic implications. Int Pediatr 10/1: 51–56Google Scholar
  10. Ehlen C, Heintges T, Niederau C (1995) Diagnose und Therapie des Morbus Gaucher. Med Klein 90/5: 284–290Google Scholar
  11. Fernandez J, Saudubray JM, Berghe D van den (eds) (1996) Inborn metabolic diseases. Diagnosis and treatment, 2nd edn. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  12. Gärtner J, Moser H, Walle D (1992) Mutations in the 70 K peroxisomal membrane protein gene in Zellweger syndrome. Nat Genet 1:16–22PubMedCrossRefGoogle Scholar
  13. Goebel HH (1997) Morphologic diagnosis in neuronal ceroid lipofuscinosis. Neuropediatrics 28:67–69PubMedCrossRefGoogle Scholar
  14. Goebel HH, Bode G, Caesar R, Kohlschütter A (1981) Bulbar palsy with Rosenthal fiber formation in the medulla of a 15-year old girl. Localized form of Alexander’s-Disease? Neuropediatrics 12: 382–391PubMedCrossRefGoogle Scholar
  15. Haltia M, Santavuori P (eds) (1997) NCL-Proceedings. Sixth International Congress on Neuronal Ceroid-Lipofuscinosis, Gustavelund, Finnland, June 8–11, 1996. Neuropediatrics 28:1–84Google Scholar
  16. Hanefeld F, Holzbach O, Kruse B, Wilichowski E, Christen HJ, Frahm NJ (1993) Diffuse white matter disease in three children: An encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 24:244–248PubMedCrossRefGoogle Scholar
  17. Harden A, Pampiglione G (1982) Neurophysiological studies (EEG/ERG/VEP/SEP) in 88 children with so called neuronal ceroid lipofuscinosis. In: Armstrong D, Koppang N, Redor JH (eds) Ceroidlipofuscinosis (Batten’s disease). Lefevier, Amsterdam, pp 61–70Google Scholar
  18. Hyland K, Surtees RAH, Rodeck C, Clayton PT (1980) Aromatic L-amino acid decarboxylase deficiency. Neurology 42: 1980–1988Google Scholar
  19. Hyland K, Buist NRM, Powell BR, Hoffman GF, Rating D, McGrath J, Acworth IN (1995) Folinic acid responsive seizures: a new syndrome? J Inher Metab Dis 18: 177–181PubMedCrossRefGoogle Scholar
  20. Ichinose H, Ohye T, Takahashi E et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8: 236–242PubMedCrossRefGoogle Scholar
  21. Jaeken J, Carchon H (1993) The carbohydrate-deficient glycoprotein syndromes: An overview. J Inher Metab Dis 16: 813–820PubMedCrossRefGoogle Scholar
  22. Jaeken J, Detheux M, Mandergem L van et al. (1996) 3-Phos-phoglycerate dehydrogenase deficiency and 3-phospho-serine phosphatase deficiency: Inborn errors of serine biosynthesis. J Inher Metab Dis 19:223–226PubMedCrossRefGoogle Scholar
  23. Kobayashi Y, Momoi MY, Tominaga K et al. (1990) A point mutation in the mitocondrial tRNAleu (UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes). Biochem Biophys Res Commun 173:816–822PubMedCrossRefGoogle Scholar
  24. Lalley PA, Rattazzi MC, Shows TB (1974) Human β-D-N-Acetylhexosaminidase A and B: Expression and linkage relationships in somatic cell hybrids. Proc Nat Acad Sci USA 71:1569PubMedCrossRefGoogle Scholar
  25. Matthijs G, Schollen E, Pardon E, Veiga Da Cunha M, Jaeken J, Cassiman JJ, Schaftingen E van (1997) Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). In: Menkes JH (ed) Textbook of child-neurology, 4th edn. Lea & Febiger, PhiladelphiaGoogle Scholar
  26. Moser AB, Borel J, Odone A, Naidu S, Cornblath D, Sanders DB, Moser HW (1987) A new dietary therapy for adrenoleuko-dystrophy: biochemical and preliminary clinical results in 36 patients. Ann Neurol 21:240–249PubMedCrossRefGoogle Scholar
  27. Motley AM, Hettema EH, Hogenhout EM et al. (1997) Rhizo-melic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet 15: 377–380PubMedCrossRefGoogle Scholar
  28. Schindler D, Bishop TF, Wolfe DE, Wang AW, Egge H, Lemieux RO, Desnick RJ (1989) Neuroaxonal dystrophy due to lysosomal N-acetyl-galactose-aminidase-deficiency. N Engl J Med 320:1735–1740PubMedCrossRefGoogle Scholar
  29. Scriver CR, Beaudet AL, Sly WS, Valle D (eds) (1995) The metabolic and molecular bases of inherited disease, 7th edn. Mc Graw-Hill, LondonGoogle Scholar
  30. Segawa M, Hosaka A, Miyagawa F, Noumora Y, Imai H (1976) Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 14: 215–233PubMedGoogle Scholar
  31. Sharp JD, Wheeler RB, Lake BD et al. (1997) Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 1 lp15 and 15q21–23. Hum Mol Genet 6:591–595PubMedCrossRefGoogle Scholar
  32. Simmonds HA (1996) Purine and pyrimidine disorders. In: Blau N, Duran M, Blaskovics M (eds) A Physician’s Guide to Laboratory Diagnosis of Inherited Metabolic Disease. Chapter 21, pp 341–356Google Scholar
  33. Stöckler S, Holzbach U, Hanefeld F et al. (1994) Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pediatric Res 36/3:409–413CrossRefGoogle Scholar
  34. Stöckler S, Hanefeld F, Frahm J (1996) Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789–790PubMedCrossRefGoogle Scholar
  35. Taylor TD, Litt M, Kramer P (1996) Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20pl.3-pl3. Nat Genet 14:479–481PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • G. Göhlich-Ratmann
  • T. Voit

There are no affiliations available

Personalised recommendations